# Observation Study on Reducing the Risk of Liver Cancer Associated With Hepatitis B (Zhiyuan) Project.

> **NCT07169656** · — · RECRUITING · sponsor: **The First Affiliated Hospital of Zhengzhou University** · enrollment: 15000 (estimated)

## Conditions studied

- Chronic Hepatitis b

## Interventions

- **DRUG:** ETV,TDF,TAF,TMF
- **DRUG:** Peginterferon α-2b injection

## Key facts

- **NCT ID:** NCT07169656
- **Lead sponsor:** The First Affiliated Hospital of Zhengzhou University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2024-06-03
- **Primary completion:** 2032-06-30
- **Final completion:** 2032-12-31
- **Target enrollment:** 15000 (ESTIMATED)
- **Last updated:** 2025-09-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07169656

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07169656, "Observation Study on Reducing the Risk of Liver Cancer Associated With Hepatitis B (Zhiyuan) Project.". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07169656. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*